Patients with laryngeal cancer who stopped smoking before receiving treatment had better survival outcomes, compared with ...

Research has shown aspirin use to be associated with lower rates of metastasis for some patients. Aspirin use may be ...

Receiving early transfusions and treatment to reduce transfusion dependency significantly improves survival and quality of ...

My cancer diagnosis of non-Hodgkin lymphoma took a circuitous route that would make the greatest explorer get lost, even with ...

During this in-person event, over 500 attendees celebrated the remarkable efforts made by oncology nurses in the care of ...

With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers ...

Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many ...

The FDA has granted accelerated approval to Ojemda for patients 6 months and older with relapsed or refractory pediatric ...

At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying ...

Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.

The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute ...